| Date | Title | Description | Source |
| 08.03.2024 | NodThera says inflammation drug has positive effect in Parki... | - | fprimecapi... |
| 07.03.2024 | NodThera’s NLRP3 Inhibitor NT-0796 Reverses Neuroinflammatio... | - | globenewsw... |
| 20.02.2024 | NodThera Touts Potential Weight Loss Effect of NLRP3 Inhibit... | - | fprimecapi... |
| 03.06.2020 | NodThera Announces Close of $55 Million Series B Financing | - | fprimecapi... |
| 03.06.2020 | NodThera Raises $55M (£44M) in Series B Financing | NodThera, a UK and US based clinical stage biotechnology company developing a new class of medicines... | finsmes.co... |
| 03.06.2020 | NodThera Raises $55M In Series B | CAMBRIDGE, England & BOSTON & SEATTLE--(BUSINESS WIRE)--NodThera, a clinical stage biotechno... | citybizlis... |
| 03.06.2020 | NodThera Announces Close of $55 Million Series B Financing | - | 5amventure... |
| 08.11.2019 | Cambridge companies recognised at industry leading OBN Award... | Cambridge companies recognised at industry leading OBN Awards 2019 event
08-11-2019
Cambridge Networ... | cambridgen... |
| 26.06.2018 | Term Sheet — Tuesday, June 26 | VENTURE MEETS CRYPTO
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't ... | fortune.co... |
| 26.06.2018 | NodThera secures £28 million ($40 million) Series A Financin... | - | 5amventure... |
| 25.06.2018 | 5AM Ventures Leads $40M Series A for NodThera | Cambridge, UK - NodThera, a biotechnology company focused on the discovery and development of next g... | citybizlis... |
| 25.06.2018 | NodThera Secures £28M in Series A Financing | NodThera, a Cambridge, UK-based biotechnology company focused on the discovery and development of ne... | finsmes.co... |
| 25.06.2018 | Top tech startup news stories you need to know this Monday, ... | Good morning! Here are some of the top tech startup news stories for today, Monday, June 25.
Chines... | techstartu... |
| 25.06.2018 | Nodthera nets $40M to take on chronic inflammation | Cambridge, U.K.-based Nodthera raised £28 million ($40 million) in series A funding to bring an NLRP... | fiercebiot... |
| 25.06.2018 | Nodthera nets $40M to take on chronic inflammation | Cambridge, U.K.-based Nodthera raised £28 million ($40 million) in series A funding to bring an NLRP... | fiercebiot... |
